Summary

Eligibility
for males ages 18-99 (full criteria)
Healthy Volunteers
healthy people welcome
Dates
study started
estimated completion
Principal Investigator
Jaime Landman

Description

Summary

The purpose of this study is to compare changes in the body's self-defense (immune response) after two different treatments for small kidney tumors: 1) Cryoablation (freezing) therapy in which the tumor and a margin of normal kidney tissue are frozen and thawed twice with a needle probe and 2) radiofrequency ablation (RFA) in which radiofrequency energy delivered through a needle probe is used to heat tissue and thereby destroy a tumor.

Keywords

Immune Response to 3 Approaches Carcinoma, Renal Cell

Eligibility

You can join if…

Open to males ages 18-99

  • You are eligible to participate in this study if you are an adult (older than 18 years)
  • Diagnosed with renal cell cancer 1-3 centimeters in size on the CT scan.

You CAN'T join if...

  • You are not eligible to participate in this study if you are immune compromised (chemotherapy,corticosteroid use, HIV [as documented in your medical record], etc.)
  • Have an autoimmune disorders (Rheumatoid arthritis, Crohn's disease, etc)
  • Have a tumor larger than 4 cm
  • Are pregnant.

Lead Scientist at UC Irvine

  • Jaime Landman
    Professor, Urology. Authored (or co-authored) 267 research publications.

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT03409224
Study Type
Observational
Last Updated